Unichem Laboratories has entered into an agreement to acquire 20% equity stake in the API and intermediate business of Hyderabad based Optimus group. The acquisition value is Rs 120 crore. The transaction will give the company access to Optimus’ US Food and Drug Administration (USFDA) approved API manufacturing facilities and Optimus will gain from the … Read more
Unichem Laboratories has reported results for second quarter ended September 30, 2018. The company has reported a fall of 66.80% in its net profit at Rs 15.21 crore for the quarter under review as compared to Rs 45.82 crore for the same quarter in the previous year. However, total income of the company increased by … Read more
Unichem Laboratories has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) indicating closure of inspections at both the API manufacturing facilities located at Pithampur and Roha. The inspection at Pithampur was conducted by the USFDA from July 23, 2018 to July 27, 2018, while the inspection at Roha was conducted … Read more
Unichem Laboratories is currently trading at Rs. 212.00, up by 4.90 points or 2.37% from its previous closing of Rs. 207.10 on the BSE. The scrip opened at Rs. 209.95 and has touched a high and low of Rs. 219.45 and Rs. 206.40 respectively. So far 9492 shares were traded on the counter. The BSE … Read more
